candesartan and Cerebral Arterial Diseases studies

candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.

Cerebral Arterial Diseases: Pathological conditions of intracranial ARTERIES supplying the CEREBRUM. These diseases often are due to abnormalities or pathological processes in the ANTERIOR CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY; and POSTERIOR CEREBRAL ARTERY.

Research Excerpts

Excerpt	Relevance	Reference
"Head-to-head comparison suggests that treatment with aliskiren before and during cerebral ischemia is at least as effective as candesartan in double transgenic rats."	7.76	Effects of aliskiren on stroke in rats expressing human renin and angiotensinogen genes. ( Culman, J; Hocher, B; Mueller, S; Muller, DN; Pfab, T; Schmerbach, K; Thoene-Reineke, C; Unger, T; Villringer, A; Zhao, Y, 2010)
"Head-to-head comparison suggests that treatment with aliskiren before and during cerebral ischemia is at least as effective as candesartan in double transgenic rats."	3.76	Effects of aliskiren on stroke in rats expressing human renin and angiotensinogen genes. ( Culman, J; Hocher, B; Mueller, S; Muller, DN; Pfab, T; Schmerbach, K; Thoene-Reineke, C; Unger, T; Villringer, A; Zhao, Y, 2010)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

candesartan and Cerebral Arterial Diseases

Research Excerpts

Research

Studies (1)

Authors

Other Studies

Authors	Studies
Schmerbach, K	1
Pfab, T	1
Zhao, Y	1
Culman, J	1
Mueller, S	1
Villringer, A	1
Muller, DN	1
Hocher, B	1
Unger, T	1
Thoene-Reineke, C	1